Journal Information
Vol. 159. Issue 9.
Pages e61 (November 2022)
Vol. 159. Issue 9.
Pages e61 (November 2022)
Letter to the Editor
Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
Anticoagulantes orales de acción directa (ACOD) en pacientes con fibrilación auricular durante la pandemia de COVID-19
Visits
37
a School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia
b School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia
c School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom
d School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia
This item has received
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail